Systematic review of cost and cost-effectiveness of different TB-screening strategies
作者： Albert Nienhaus , Anja Schablon , José Torres Costa , Roland Diel
关键词: Critical appraisal 、 Medicine 、 Intensive care medicine 、 Pathology 、 MEDLINE 、 Tuberculin 、 Cost–benefit analysis 、 Cost effectiveness 、 Latent tuberculosis 、 Tuberculosis 、 Health administration
摘要: … Sensitivity is defined as the proportion of persons with true latent TB infection proportion who test positive with the screening test. Specificity is defined as the number of true negatives in …
biomedcentral.com
springer.com
mendeley.com参考文章(28)
S Deuffic-Burban, E Bouvet, Y Yazdanpanah, K Atsou, H Melliez, N Viget, Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection. International Journal of Tuberculosis and Lung Disease. ,vol. 14, pp. 471- 481 ,(2010)
O Oxlade, D Menzies, K Schwartzman, Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. International Journal of Tuberculosis and Lung Disease. ,vol. 11, pp. 16- 26 ,(2007)
M. Sadatsafavi, R. C. Brunham, R. K. Elwood, M. Morshed, F. Marra, V. Cook, C. A. Marra, O. Moran-Mendoza, J. M. Fitzgerald, Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts. International Journal of Tuberculosis and Lung Disease. ,vol. 12, pp. 1414- 1424 ,(2008)
R. Diel, T. Schaberg, R. Loddenkemper, T. Welte, A. Nienhaus, Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany Respiratory Medicine. ,vol. 103, pp. 1838- 1853 ,(2009) , 10.1016/J.RMED.2009.07.008
Marie A. de Perio, Joel Tsevat, Gary A. Roselle, Stephen M. Kralovic, Mark H. Eckman, Cost-effectiveness of Interferon Gamma Release Assays vs Tuberculin Skin Tests in Health Care Workers JAMA Internal Medicine. ,vol. 169, pp. 179- 187 ,(2009) , 10.1001/ARCHINTERNMED.2008.524
Dick Menzies, Madhukar Pai, George Comstock, Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Annals of Internal Medicine. ,vol. 146, pp. 340- 354 ,(2007) , 10.7326/0003-4819-146-5-200703060-00006
Madhukar Pai, Lee W Riley, John M Colford, Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review Lancet Infectious Diseases. ,vol. 4, pp. 761- 776 ,(2004) , 10.1016/S1473-3099(04)01206-X
Roland Diel, Robert Loddenkemper, Albert Nienhaus, Evidence-Based Comparison of Commercial Interferon-γ Release Assays for Detecting Active TB: A Metaanalysis Chest. ,vol. 137, pp. 952- 968 ,(2010) , 10.1378/CHEST.09-2350
Payam Nahid, Madhukar Pai, Philip C Hopewell, Advances in the diagnosis and treatment of tuberculosis. Proceedings of the American Thoracic Society. ,vol. 3, pp. 103- 110 ,(2006) , 10.1513/PATS.200511-119JH
Akiko Kowada, Osamu Takahashi, Takuro Shimbo, Sachiko Ohde, Yasuharu Tokuda, Tsuguya Fukui, Cost Effectiveness of Interferon-γ Release Assay for Tuberculosis Contact Screening in Japan Molecular Diagnosis & Therapy. ,vol. 12, pp. 235- 251 ,(2008) , 10.1007/BF03256289